Has Fred Kudrik, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,434 in general payments to Fred Kudrik, MD across 368 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Fred Kudrik, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Fred Kudrik, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Fred Kudrik, MD

Hematology & Oncology · Columbia, SCNPI 1104807668

Payments from drug & device makers

$20,434in general payments, 2019–2025

Across 368 payments — averaging $55.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Genentech, Inc.$5K
AstraZeneca$3K
Blueprint Medicines Corporation$1K
E.r. Squibb & Sons, L.L.C.$1K
Novocure Inc.$1K
Novartis$1K
plus $7K from 53 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Genentech, Inc.	2	$5,254
AstraZeneca	10	$2,930
Blueprint Medicines Corporation	2	$1,480
E.r. Squibb & Sons, L.L.C.	24	$1,419
Novocure Inc.	4	$1,333
Novartis	46	$1,108
Amgen	8	$510
Bristol Myers Squibb	23	$419
Johnson & Johnson(2 entities)	22	$395
Pfizer	22	$365
Gilead	14	$356
Merck	14	$332
Astellas Pharma US Inc	16	$301
Heron Therapeutics, Inc.	2	$282
Janssen Scientific Affairs, LLC	2	$266
Genentech USA, Inc.	13	$260
ASD Specialty Healthcare, LLC	3	$241
Takeda Pharmaceuticals U.S.A., Inc.	16	$209
Daiichi Sankyo Inc.	8	$202
Eagle Pharmaceuticals, Inc.	4	$187
EMD Serono, Inc.	8	$174
Octapharma USA, Inc.	1	$152
Rigel Pharmaceuticals, Inc.	6	$144
Array Biopharma Inc	9	$118
Lilly USA, LLC	6	$116
AbbVie	5	$116
Incyte Corporation	5	$115
ADC Therapeutics America, Inc.	5	$114
AVEO Pharmaceuticals, Inc.	5	$102
Comsort, Inc	1	$100
Sanofi	4	$99
Bayer	5	$97
Pharmacyclics LLC, An Abbvie Company	3	$86
Jazz Pharmaceuticals Inc.	5	$82
Boehringer Ingelheim	3	$79
Ipsen Biopharmaceuticals, Inc	3	$78
Mirati Therapeutics, Inc.	3	$72
Karyopharm Therapeutics Inc.	4	$69
GSK	2	$66
Puma Biotechnology, Inc.	3	$55
Genmab U.S., Inc.	2	$55
Deciphera Pharmaceuticals Inc.	2	$52
Seagen Inc.	3	$46
Regeneron Healthcare Solutions, Inc.	2	$46
Immunocore Limited	2	$45
Beone Medicines USA, Inc.	2	$37
Springworks Therapeutics, Inc.	2	$36
Immunogen, Inc.	1	$31
Taiho Oncology, Inc.	1	$25
Servier Pharmaceuticals LLC	1	$24
Eisai Inc.	1	$23
Dova Pharmaceuticals	1	$23
Sumitomo Pharma America, Inc.	1	$18
Epizyme, Inc.	1	$17
Morphosys, US Inc.	1	$17
Pharmacosmos Therapeutics Inc.	1	$15
Exelixis Inc.	1	$14
Helsinn Therapeutics (U.S.), Inc.	1	$13
Agios Pharmaceuticals, Inc.	1	$12

How this compares

$20,434 in reported general payments places this provider in the 65th percentile of 166 hematology & oncology providers in South Carolina.

See all hematology & oncology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$6,211,138

Medicare patients

1,233

Services billed

343,894

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Columbia

Anne HutchisonColumbia$52K
Ki ChungSpartanburg$4.7M
Stephen DyarGreenville$4.5M
Suzanne FanningGreenville$3.9M
Vikas DemblaSpartanburg$3.2M
Robert StuartCharleston$2.9M
Tondre BuckSpartanburg$2.1M
William EdenfieldGreenville$1.7M
Bhumika PatelGreenville$1.5M
Elizabeth CullGreenville$1.2M

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →